A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis

NCT06306781 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Decompensated Cirrhosis

Interventions

DRUG: HCL001 cell (homologous allogeneic hepatocytes) injection

Sponsor

RenJi Hospital